Pharmaceutical Fine Chemicals Market is driven by Rising Demand for Active Pharmaceutical Ingredients
The Global pharmaceutical fine chemicals Market is estimated to be valued at US$ 136.2 billion in 2024 and is expected to exhibit a CAGR of 7.9% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the pharmaceutical fine chemicals are Denisco, Albemarle Corporation, Kenko Corporation, GRACE, CHEMADA, JMP Statistical Discovery LLC., Pfizer Inc. and GSK plc. These major companies have large production facilities and collaborate with drug manufacturers for development and supply of APIs and intermediates.
Pharmaceutical Fine Chemicals Market Demand is growing steadily due to increasing generics production and biosimilars development post-patent expiry of major blockbuster drugs. Manufacturers are investing heavily in developing integrated facilities with capabilities for complex synthesis and isolation of novel molecules.
The global pharmaceutical fine chemicals market is also expanding into high-growth emerging markets of Asia Pacific and Middle East & Africa. Setting up of cost-effective production units and partnerships with local pharma companies will help major players enhance their regional presence.
Get More Insights on Pharmaceutical Fine Chemicals Market
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian